WeVote
Log In

Bill

LD

Bill

HB 2313

Prohibits the use of fetal organs or tissue resulting from elective abortions for medical, scientific, research, experimental, or therapeutic purposes or any other use

2026 Regular Session Introduced by Lisa Durnell and 1 co-sponsor

Missouri HB 2313 bans using fetal organs or tissue from elective abortions for any medical, scientific, or therapeutic purpose and forbids inducements to obtain such tissue.

Referred: Emerging Issues(H)
#abortion #healthcareprofessionals #scienceandtechnology
0
WeVote Research Nonpartisan
Bill Summary · HB 2313

Overview

Missouri House Bill 2313 (2026) would prohibit the use of fetal organs or tissue resulting from elective abortions for medical, scientific, research, experimental, therapeutic purposes, or any other use. The bill repeals current law and enacts a new provision under Section 188.036 that bans abortion procedures intended to facilitate the use of fetal tissue for such purposes, prohibits the use of fetal tissue obtained from an abortion, and bars inducements or payments related to procuring or using fetal tissue. It includes a severability clause.

Main purpose and intent

  • To prohibit the use of fetal organs or tissue resulting from elective abortions for medical transplantation, research, or any other use.
  • To criminalize actions that knowingly facilitate or profit from abortions or fetal tissue for these purposes.
  • To deter inducements (financial or other) related to conceptions or abortions intended for obtaining fetal tissue.
  • To ensure burial, final disposition, or pathological examination of fetal remains are not used as a basis for payment or incentive related to fetal tissue use.

Key provisions and changes

  • Section 188.036 (new enacted text):

    • Prohibits a physician from performing an abortion if they know the abortion is being sought for the purpose of procuring fetal organs or tissue for transplantation to the woman or another person, and the abortion is intended for that purpose.
    • Prohibits any person from using fetal organs or tissue from an abortion for medical transplantation if they know the abortion was procured for that use.
    • Prohibits offering inducements (monetary or otherwise) to a woman or prospective father to conceive a child for the purpose of using fetal tissue for medical, scientific, experimental, or therapeutic purposes.
    • Prohibits inducements to the mother or father to procure an abortion for such uses.
    • Prohibits knowingly offering or receiving valuable consideration for fetal organs or tissue from an abortion, with an exception only for burial/final disposition payments or payments for pathological examination (as stated to be restricted).
    • Broad prohibition on utilizing fetal organs or tissue from an elective abortion for any medical, scientific, research, experimental, therapeutic, or other use.
    • Severability clause: if any provision is invalid, the rest remains in effect.

  • Structure: Replaces the existing statute (188.036) with a new section carrying the same number but updated language and scope.

Who is affected

  • Physicians performing abortions: restricted from abortions intended to obtain fetal tissue for transplantation or other uses.
  • Individuals or entities seeking to use fetal organs or tissue from abortions: barred from such use if known to be procured for that purpose.
  • Anyone offering inducements to conceive or procure an abortion for fetal tissue use: prohibited.
  • Individuals or entities involved in acquiring, transferring, or handling fetal tissue from abortions: prohibited from using it for specified purposes.
  • The measure targets medical, scientific, research, experimental, and therapeutic contexts involving fetal tissue.

Procedural and timeline aspects

  • Action history shows introduction in 2025 as prefiled, with current actions in 2026:
    • Prefiled in December 2025.
    • Referred to Emerging Issues (H) on May 15, 2026.
    • Past readings include Second Time (January 8, 2026) and First Time (January 7, 2026).
  • Sponsor: Representative Deanna Self; co-sponsors: Lisa Durnell and Deanna Self (primary) with additional co-sponsor listed.
  • The bill modifies existing Missouri law by repealing Section 188.036 and enacting a new, more expansive set of prohibitions.

Potential impact and considerations

  • Legal status of abortion procedures could be affected if abortions are sought specifically to obtain fetal tissue for transplantation or research.
  • Potential criminal or civil exposure for providers, institutions, or individuals who breach the prohibitions, including provisions against inducements.
  • Aligns Missouri policy with strict prohibitions on fetal tissue use, potentially limiting medical research and transplantation practices involving fetal organs or tissue derived from elective abortions.
  • The text does not specify penalties, enforcement mechanisms, or exceptions beyond the explicit prohibitions and the severability clause; those details would be clarified in the enacted statute and related enforcement provisions if passed.

If you’d like, I can compare HB 2313 to HB 163 (2025) or provide a side-by-side summary of differences and potential policy implications.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.